PBH
Prestige Consumer Healthcare Inc.
NYSE · Healthcare · Medical - Distribution · US
$52.26
−0.57%Year over year
Reported trailing growth
- Revenue
- -1.4%
- EBITDA
- -13.0%
- EBIT
- -13.8%
- EPS
- -16.5%
- Free cash flow
- -12.1%
- Operating cash flow
- -9.6%
Forward estimates
Based on analyst estimates
- Revenue
- +23.0%
- EBITDA
- +17.1%
- EPS
- +30.9%
Three-year CAGR
- Revenue
- -1.2%
- EBITDA
- +247.7%
- EBIT
- -4.9%
- Net income
- -4.7%
- EPS
- -3.4%
- Free cash flow
- +3.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026